Ken Griffin Third Harmonic Bio, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 56,300 shares of THRD stock, worth $289,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,300

Previous 100 56200.0%

Holding current value

$289,945

Previous $1,000 19400.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$3.25 - $11.17 $95,030 - $326,610	29,240 Added 27.45%	135,774 $471,000
Q4 2024 Feb 14, 2025	SELL	$10.29 - $15.4 $5.16 Million - $7.73 Million	-501,639 Reduced 82.48%	106,534 $1.1 Million
Q3 2024 Nov 14, 2024	SELL	$10.86 - $15.0 $788,381 - $1.09 Million	-72,595 Reduced 10.66%	608,173 $8.24 Million
Q2 2024 Aug 14, 2024	BUY	$8.74 - $15.54 $5.95 Million - $10.6 Million	680,768 New	680,768 $8.85 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $11.47 $2.17 Million - $4.16 Million	363,028 New	363,028 $3.98 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $4.49 $42,359 - $48,150	10,724 New	10,724 $44,000
Q3 2022 Nov 14, 2022	BUY	$16.75 - $19.93 $966,257 - $1.15 Million	57,687 New	57,687 $1.1 Million

Others Institutions Holding THRD

# of Institutions

Shares Held

38.5M

Call Options Held

76.6K

Put Options Held

22.8K

View Full List

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $208M

More about THRD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account